For the quarter ended December 2025, Avantor, Inc. (AVTR) reported revenue of $1.66 billion, down 1.4% over the same period last year. EPS came in at $0.22, compared to $0.27 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $1.62 billion, representing a surprise of +3%. The company delivered an EPS surprise of +2.85%, with the consensus EPS estimate being $0.21.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Avantor performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Bioscience Production: $547.5 million compared to the $545.34 million average estimate based on five analysts. The reported number represents a change of -2.4% year over year.
- Revenue- Laboratory Solutions: $1.12 billion compared to the $1.06 billion average estimate based on five analysts. The reported number represents a change of -0.9% year over year.
- Adjusted Operating Income- Laboratory Solutions: $114.4 million versus $118.63 million estimated by three analysts on average.
- Adjusted Operating Income- Corporate: $-16 million compared to the $-18.11 million average estimate based on three analysts.
- Adjusted Operating Income- Bioscience Production: $127 million compared to the $122.96 million average estimate based on three analysts.
View all Key Company Metrics for Avantor here>>>
Shares of Avantor have returned -11.4% over the past month versus the Zacks S&P 500 composite's -0.3% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Avantor, Inc. (AVTR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
